Saori Takata

503 total citations
37 papers, 347 citations indexed

About

Saori Takata is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Saori Takata has authored 37 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 8 papers in Epidemiology. Recurrent topics in Saori Takata's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Asthma and respiratory diseases (5 papers). Saori Takata is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Asthma and respiratory diseases (5 papers). Saori Takata collaborates with scholars based in Japan, United States and Israel. Saori Takata's co-authors include Haruyuki Ishii, Takeshi Saraya, Hajime Takizawa, Hajime Goto, Daisuke Kurai, Keitaro Nakamoto, Hiroo Wada, Takuma Yokoyama, Masuo Nakamura and Masaki Tamura and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Clinical Microbiology.

In The Last Decade

Saori Takata

30 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saori Takata Japan 11 113 89 82 63 60 37 347
Huaqiong Huang China 13 110 1.0× 94 1.1× 74 0.9× 135 2.1× 35 0.6× 41 440
Yoshifumi Kimizuka Japan 12 83 0.7× 170 1.9× 39 0.5× 19 0.3× 82 1.4× 47 398
Sofya Tokman United States 10 110 1.0× 175 2.0× 58 0.7× 43 0.7× 57 0.9× 44 390
Almerico Marruchella Italy 9 207 1.8× 168 1.9× 35 0.4× 66 1.0× 125 2.1× 22 401
Zerina Hodzic United States 6 135 1.2× 83 0.9× 135 1.6× 28 0.4× 54 0.9× 6 508
Christopher D. Beaty United States 6 110 1.0× 80 0.9× 49 0.6× 34 0.5× 30 0.5× 11 339
Shravani Pasupneti United States 10 93 0.8× 48 0.5× 50 0.6× 25 0.4× 57 0.9× 16 264
Yohei Funatsu Japan 14 173 1.5× 232 2.6× 42 0.5× 27 0.4× 128 2.1× 27 436
Tarah D. Holden United States 7 92 0.8× 106 1.2× 108 1.3× 38 0.6× 33 0.6× 9 368
Tracy R. McMillan United States 7 138 1.2× 115 1.3× 50 0.6× 40 0.6× 23 0.4× 9 397

Countries citing papers authored by Saori Takata

Since Specialization
Citations

This map shows the geographic impact of Saori Takata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saori Takata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saori Takata more than expected).

Fields of papers citing papers by Saori Takata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saori Takata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saori Takata. The network helps show where Saori Takata may publish in the future.

Co-authorship network of co-authors of Saori Takata

This figure shows the co-authorship network connecting the top 25 collaborators of Saori Takata. A scholar is included among the top collaborators of Saori Takata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saori Takata. Saori Takata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nakamoto, Keitaro, Masato Watanabe, Yuki Yoshida, et al.. (2024). Serum Derivatives–Reactive Oxygen Metabolite Levels as a Marker of Clinical Conditions in Patients with Bronchial Asthma, COPD, or Asthma–COPD Overlap: A Prospective Study. Journal of Clinical Medicine. 13(19). 6022–6022. 2 indexed citations
3.
Nakamichi, Shinji, Kaoru Kubota, Toshihiro Misumi, et al.. (2024). Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non–small Cell Lung Cancer: TORG1937 (DATE Study). Clinical Cancer Research. 30(6). 1104–1110. 8 indexed citations
4.
Kobayashi, Fumi, Takeshi Saraya, Ryo Takagi, et al.. (2024). Impact of Cough Severity on the Diagnostic Yield of Endobronchial Ultrasonography Transbronchial Biopsy with Guide Sheath: A Retrospective Observational Study. Journal of Clinical Medicine. 13(2). 347–347. 2 indexed citations
5.
Kondo, Tetsuro, Kaoru Kubota, Shinji Nakamichi, et al.. (2023). 1294P A final analysis of a phase II study of durvalumab immediately after completion of chemoradiotherapy in unresectable stage III non–small-cell lung cancer: TORG1937 (DATE study). Annals of Oncology. 34. S746–S747. 1 indexed citations
6.
Nakamichi, Shinji, Kaoru Kubota, Toshihiro Misumi, et al.. (2022). A phase II study of durvalumab (MEDI4736) immediately after completion of chemoradiotherapy in unresectable stage III non–small cell lung cancer: TORG1937 (DATE study).. Journal of Clinical Oncology. 40(16_suppl). 8536–8536. 4 indexed citations
7.
8.
Zenke, Yoshitaka, Shingo Matsumoto, Terufumi Kato, et al.. (2020). Clinical impact of targetable gene alterations on therapeutic outcomes in stage II/III locally advanced non-small cell lung cancer patients.. Journal of Clinical Oncology. 38(15_suppl). 9038–9038. 3 indexed citations
9.
Morikawa, Kei, Hisashi Tanaka, Saori Takata, et al.. (2020). Hypothesis generative head-to-head study comparing efficacy of afatinib and osimertinib based on immunological biomarkers in Japanese NSCLC patients with EGFR mutations (Heat on Beat study). Therapeutic Advances in Medical Oncology. 12. 3863582294–3863582294. 6 indexed citations
10.
11.
Koide, Takashi, Takeshi Saraya, Francesco Bonella, et al.. (2016). Clinical significance of the "galaxy sign" in patients with pulmonary sarcoidosis in a Japanese single-center cohort.. PubMed. 33(3). 247–252. 10 indexed citations
12.
Nakamura, Masuo, Hiroo Wada, Kojiro Honda, et al.. (2015). Clarithromycin ameliorates pulmonary inflammation induced by short term cigarette smoke exposure in mice. Pulmonary Pharmacology & Therapeutics. 35. 60–66. 8 indexed citations
13.
Saraya, Takeshi, Takayasu Watanabe, Saori Takata, et al.. (2014). [Case of candidemia with Candida glabrata with confirmation of the acquisition of micafungin sensitivity due to new mutation of FKS gene mutation].. PubMed. 88(3 Suppl 9-10). 1–5.
14.
Saraya, Takeshi, Shinji Sato, Takayasu Watanabe, et al.. (2014). Mechanic’s hands revisited: is this sign still useful for diagnosis in patients with lung involvement of collagen vascular diseases?. BMC Research Notes. 7(1). 303–303. 15 indexed citations
15.
Saraya, Takeshi, Mitsuru Sada, Yasutaka Tanaka, et al.. (2014). Renal Salt Wasting Syndrome due to Carboplatin in a Patient with Lung Cancer. 1(1). 9–12.
16.
Saraya, Takeshi, Saori Takata, Masachika Fujiwara, & Hidefumi Takei. (2013). Cellular non-specific interstitial pneumonia masquerading as congestive heart failure. BMJ Case Reports. 2013. bcr2013010502–bcr2013010502.
17.
Tamura, Masaki, Masato Watanabe, Akira Nakajima, et al.. (2013). Serial quantification of procalcitonin (PCT) predicts clinical outcome and prognosis in patients with community-acquired pneumonia (CAP). Journal of Infection and Chemotherapy. 20(2). 97–103. 25 indexed citations
18.
Saraya, Takeshi, Ken Kikuchi, Saori Takata, et al.. (2012). High-resolution CT findings of patients with pulmonary nocardiosis.. Europe PMC (PubMed Central). 22 indexed citations
19.
Nakajima, Akira, Takeshi Saraya, Saori Takata, et al.. (2012). The saw-tooth sign as a clinical clue for intrathoracic central airway obstruction. BMC Research Notes. 5(1). 388–388. 3 indexed citations
20.
Takata, Saori, Hiroo Wada, Masaki Tamura, et al.. (2011). Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times. Biomarkers. 16(6). 530–535. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huaqiong Huang Breakdown of academic impact, for papers by Yoshifumi Kimizuka Breakdown of academic impact, for papers by Sofya Tokman Breakdown of academic impact, for papers by Almerico Marruchella Breakdown of academic impact, for papers by Zerina Hodzic Breakdown of academic impact, for papers by Christopher D. Beaty Breakdown of academic impact, for papers by Shravani Pasupneti Breakdown of academic impact, for papers by Yohei Funatsu Breakdown of academic impact, for papers by Tarah D. Holden Breakdown of academic impact, for papers by Tracy R. McMillan
Rankless by CCL
2026